STEPHEN P.A. FODOR, PH.D.

Corporate Board Profile

Tech Score: 0/100

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... The Nominating and Corporate Governance Committee is chaired by Dr. Fodor, and also includes Mr. Fust and Dr. Pearce.

Filing Date

Source Excerpt

2008-04-29

Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... The Nominating and Corporate Governance Committee is chaired by Dr. Fodor, and also includes Mr. Fust and Dr. Pearce.

Data sourced from SEC filings. Last updated: 2026-03-09